Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mayo Clinic researchers discover green tea component helps kill leukemia cells

01.04.2004


Mayo Clinic researchers have discovered that a component in green tea helps kill cells of the most common leukemia in the United States.



The research using laboratory cell cultures shows that a component of green tea known as epigallocatechin-3-gallate (EGCG) [epi-gallo-cat-ekin-3-gal-ate] helps kill leukemia cells by interrupting the communication signals they need to survive. The findings are reported in an early electronic article in the journal Blood (http://www.bloodjournal.org/cgi/reprint/2003-08-2763v1).

The leukemia cells studied were from patients with B-cell chronic lymphocytic leukemia (CLL) -- most often diagnosed in patients in their mid-to-late 60s. Currently, there is no cure for CLL, though chemotherapy is administered in the most severe cases. The Mayo Clinic study, led by Neil E. Kay, M.D., shows that green tea’s EGCG interrupted survival signals, prompting leukemia cells to die in eight of 10 patient samples tested in the laboratory.


Says Dr. Kay: "We’re continuing to look for therapeutic agents that are nontoxic to the patient but kill cancer cells, and this finding with EGCG is an excellent start. Understanding this mechanism and getting these positive early results gives us a lot to work with in terms of offering patients with this disease more effective, easily tolerated therapies earlier."

About the Leukemia called CLL

CLL affects individuals differently in the pace at which it progresses. Some patients may live with it for decades and not require treatment, while others need immediate treatment, and some die within months despite therapy.

Because the course of the CLL is so individualistic and unpredictable, physicians have historically adopted an attitude of "watchful waiting" with early-stage CLL patients. This rationale -- to spare elderly patients exposure to toxic chemotherapy -- has been challenged recently as new tests have improved physicians’ ability to identify early stage patients who have a more aggressive form of the cancer.

As a result, much CLL research is focused on identifying which initial-stage patients should be treated earlier in the course of their disease -- the topic of another recent article by Mayo Clinic researchers (Blood, Feb 2004; 103: 1202 - 1210.)

Significance of the Mayo Clinic Finding

The CLL characteristics make this finding even more important, as it suggests a new, nontoxic treatment. First author Yean K. Lee comments, "With these findings we may be able to pursue the idea of culling out early-stage patients who have historically not been treated and perhaps use an EGCG-based treatment. That’s our next step with our research."

Mayo Clinic CLL researcher Tait D. Shanafelt, M.D., is likewise encouraged. "Our research goal is to identify new treatments for CLL that have a favorable side effect profile and can be used in patients with early stage disease to prevent progression. I think we’re getting there."

Why Green Tea?

Mayo Clinic researchers focused on green tea for at least three reasons. One, since the 1970s, epidemiological studies of cancer have shown that in parts of the world where green tea is consumed, the incidence of solid tumor cancers such as breast, lung and gastrointestinal cancers is lower. Secondly, mouse-model testing of green tea’s cancer-prevention properties has shown they protect against solid tumors. And three, in the laboratory, the EGCG component of green tea has been proven to induce death in cancer cells from solid tumors.

The Mayo Clinic research suggests EGCG works by inhibiting a pathway in the leukemia cells related to angiogenesis -- the complex process that maintains nourishing blood flow to a biological structure, in this case a cancer cell.

Bob Nellis | EurekAlert!
Further information:
http://www.bloodjournal.org/cgi/reprint/2003-08-2763v1
http://www.mayo.edu/

More articles from Health and Medicine:

nachricht New study points the way to therapy for rare cancer that targets the young
22.11.2017 | Rockefeller University

nachricht Penn study identifies new malaria parasites in wild bonobos
21.11.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Frictional Heat Powers Hydrothermal Activity on Enceladus

Computer simulation shows how the icy moon heats water in a porous rock core

Heat from the friction of rocks caused by tidal forces could be the “engine” for the hydrothermal activity on Saturn's moon Enceladus. This presupposes that...

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Underwater acoustic localization of marine mammals and vehicles

23.11.2017 | Information Technology

Enhancing the quantum sensing capabilities of diamond

23.11.2017 | Physics and Astronomy

Meadows beat out shrubs when it comes to storing carbon

23.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>